Ksharasutra: Benefits, Evidence & Safety

TL;DR

Ksharasutra is a medicated surgical thread, linen coated with alkaline ash of Apamarga, Snuhi latex, and turmeric, used by trained surgeons to treat fistula-in-ano, cutting and healing the tract at once. An ICMR multicentric randomized trial (1991) reported cure rates comparing favorably with conventional surgery. (56 words. Sources: Sushruta Samhita; Shukla et al., 1991.)

What it is

Ksharasutra (also spelled Kshara Sutra) is not a herb but a medicated thread used as a surgical seton. A surgical linen thread is coated in multiple layers with three ingredients: alkaline ash (kshara) of Apamarga (Achyranthes aspera), the latex of Snuhi (Euphorbia neriifolia), and Haridra (turmeric) powder: prepared under aseptic conditions according to classical methods in Ayurvedic pharmacies (preparation description). The classical basis is the Sushruta Samhita (Chikitsa Sthana, chapter 8), the Ayurvedic surgical text that describes kshara-based management of Bhagandara (fistula-in-ano) (classical citation).

The thread works in two ways: the tight ligation mechanically cuts through the fistulous tract over days to weeks, while the caustic (kshara) coating chemically debrides the tract lining: so the wound cuts and heals simultaneously behind the thread, preserving the anal sphincter muscle that conventional cutting surgery may damage (mechanism description). The thread is replaced ("changed") by the surgeon at intervals until the tract is laid open and healed.

Traditional use

Ksharasutra is a classical Ayurvedic surgical (Shalya) procedure for Bhagandara (fistula-in-ano), described in the Sushruta Samhita. In classical practice it is an ambulatory, office-style treatment: no large open wound is created, and patients typically return to normal activity quickly. These traditional claims about its effectiveness are now partly testable against modern trials: see below.

What modern research says

Ksharasutra is one of the few Ayurvedic procedures tested in randomized trials. The evidence base includes:

The landmark ICMR multicentric randomized trial

The Indian Council of Medical Research conducted a multicentric randomized controlled clinical trial of Ksharasutra in the management of fistula-in-ano, published by Shukla, Narang, Nair, Radhakrishna, and Satyavati in the Indian Journal of Medical Research (1991; 94:177–185) (citation). Secondary reports of the trial describe high cure rates with low recurrence and negligible incontinence compared with conventional surgery: the basis for Ksharasutra's reputation as an evidence-backed Ayurvedic procedure (summary).

Ksharasutra vs fistulotomy: head-to-head randomized trial

Ho et al. (2001) ran a prospective randomized trial comparing the Ayurvedic cutting seton (Ksharasutra) with fistulotomy for low fistula-in-ano, published in Techniques in Coloproctology (citation). A 2023 comparative study of 96 patients (50 Ksharasutra, 46 fistulotomy) found the Ksharasutra group healed more slowly (mean 53.0 vs 35.7 days, p = 0.02) but lost far fewer workdays (1.19 vs 30.38 days, p < 0.001), had less recurrence, and paid much less (cost ratio 166 vs 464): with comparable infection, bleeding, and wound-scarring rates (clinical comparative study, not blinded) (full text).

Ksharasutra vs fistulectomy vs LIFT: a cautionary comparison

A 2023 prospective observational study of 60 patients (20 per arm) compared Ksharasutra, fistulectomy, and LIFT over 18 months: the LIFT arm showed the best overall outcomes, and the Ksharasutra arm showed the highest rate of grade-2 incontinence at 18 months (6/20, 30%, vs 5% for LIFT and 15% for fistulectomy) (prospective observational study, small sample) (PMC10061687). This tempers the "negligible incontinence" narrative and shows outcomes vary with technique, fistula type, and surgeon.

IFTAK: a newer refinement

The IFTAK technique (Interception of Fistula Tract with Application of Ksharasutra) treated 300 complex and recurrent fistulas with 93.33% successful healing. Post-therapy anal manometry showed a modest, statistically significant drop in resting and squeeze pressures, with only 3.67% developing mild flatus incontinence (prospective case series) (full text).

Bottom line: Ksharasutra has genuine randomized-trial support, rare in Ayurveda, but it is not uniformly superior to modern surgery; healing is slower, and incontinence risk is real in some comparisons.

Safety & contraindications

Ksharasutra is a surgeon-performed procedure, not a home remedy. The thread must be placed, tightened, and changed by a trained anorectal surgeon in a clinical setting.

FAQs

What is Ksharasutra made of?

A surgical linen thread coated in multiple layers with three ingredients: alkaline ash (kshara) of the Apamarga plant (Achyranthes aspera), latex of Snuhi (Euphorbia neriifolia), and turmeric (Haridra) powder. It is prepared in Ayurvedic pharmacies under aseptic conditions per classical methods. The caustic coating gives the thread its cutting and debriding action when placed through a fistulous tract.

How does Ksharasutra treat fistula-in-ano?

The surgeon threads it through the fistulous tract and ties it tight. Over days to weeks, the thread slowly cuts through tissue while its alkaline coating chemically debrides the tract lining, so the wound heals behind the cutting edge: 'cutting and healing' simultaneously. The thread is replaced periodically until the tract is fully laid open.

Is Ksharasutra effective for fistula-in-ano?

It has the strongest trial evidence of any Ayurvedic procedure: an ICMR multicentric randomized trial (1991) reported high cure rates versus conventional surgery, and later studies found less recurrence, fewer workdays lost, and lower cost than fistulotomy. But healing takes longer (about 53 vs 36 days in one study), and it is not uniformly better than modern techniques like LIFT.

Does Ksharasutra cause incontinence?

It can. Early reports emphasized negligible incontinence, but a 2023 study comparing Ksharasutra, fistulectomy, and LIFT found 30% of Ksharasutra patients had grade-2 incontinence at 18 months: worse than the LIFT arm. Risk depends on fistula complexity, technique, and surgeon skill. Anyone considering the procedure should ask their surgeon for realistic continence outcomes for their specific fistula type.

Is Ksharasutra painful?

Expect significant discomfort. Studies report more pain and burning with Ksharasutra than with some alternatives, plus weeks of wound discharge while the thread cuts through. On the other hand, patients in a 2023 study lost far fewer workdays (about 1 vs 30) because there is no large open surgical wound.

Who should not get Ksharasutra therapy?

It must be decided by a surgeon after examination. Complex fistulas, those with multiple tracts, abscesses, Crohn's disease, or tuberculosis need individualized assessment. There is no published safety data for use in pregnancy or children, so those groups need specialist input. It is never a do-it-yourself treatment: improper placement risks sphincter injury.

How long does Ksharasutra treatment take?

Longer than conventional surgery. In a 2023 comparative study, mean healing time was 53 days for Ksharasutra versus 36 days for fistulotomy. The thread is changed at intervals over several weeks until the tract cuts through and the resulting wound heals. Patients should plan for weeks of outpatient follow-up visits rather than a single operation.

Sources

Tier 1 (peer-reviewed journals, classical texts, official research bodies):

Tier 2 (PubMed-indexed/clinical studies):

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation.